Biofrontera Inc. (BFRI) income statement
BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$0.53−0.04 (-7.02%)
Close on Nov 20, 2026Market cap $7.87MP/E –Yield –
Biofrontera Inc. financial ratios
See a number that looks wrong?